Greater Cannabis Company (GCAN) EPS (Weighted Average and Diluted) (2022 - 2026)

Greater Cannabis Company's EPS (Weighted Average and Diluted) history runs 5 years deep, the most recent figure standing at -$0.04 for Q1 2026.

• In Q1 2026, EPS (Weighted Average and Diluted) fell 30964.57% year-over-year to -$0.04; the TTM figure through Mar 2026 stood at $0.81 (up 406.25% YoY), while the FY2025 annual figure was -$0.4, down 20.48% from the prior year.
• EPS (Weighted Average and Diluted) was -$0.04 for Q1 2026 at Greater Cannabis Company, down from $0.85 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.85 in Q4 2025 to a low of -$0.09 in Q3 2024.
• Historically, EPS (Weighted Average and Diluted) has averaged $0.06 across 5 years, with a median of -$0.0 in 2022.
• Biggest YoY gain for EPS (Weighted Average and Diluted) was 402969.46% in 2024; the steepest drop was 125218.34% in 2024.
• A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.0 in 2022, then grew by 23.05% to -$0.0 in 2023, then surged by 402969.46% to $0.25 in 2024, then surged by 240.0% to $0.85 in 2025, then slumped by 104.16% to -$0.04 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at -$0.04 (Q1 2026), $0.85 (Q4 2025), and -$0.04 (Q3 2025), per Business Quant data.